martes, 4 de junio de 2024

Patient Lung Cancer Screening Decisions and Environmental and Psychosocial Factors

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2819341?utm_medium=email&utm_source=govdelivery This study aimed to investigate environmental, psychosocial, and modifying factors influencing lung cancer screening decision-making and develop a conceptual framework depicting relationships between these factors. Author: Jennifer Richmond, Jessica R. Fernandez*, Kemberlee Bonnet, Ashley Sellers, David G. Schlundt, Allana T. Forde*, Consuelo H. Wilkins, and Melinda C. Aldrich Journal: JAMA, May 31

Drug Trials Snapshots: FILSUVEZ (birch triterpenes) topical gel

FILSUVEZ is for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-filsuvez

Vimseltinib for tenosynovial giant cell tumour

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01113-9/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_asco24&_hsenc=p2ANqtz-9AsKRbIUK5Fc0hDduznM707VBJ_U8tb6bkz6EahFDkOEDUnRsqbL6oAq93LqpCpNv_HYjgGfc0fDUGDPJ3ca2l0_oMcw&_hsmi=309962768&utm_content=309962768&utm_source=hs_email

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00885-7/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_asco24&_hsenc=p2ANqtz-9rUz-btlp1pIp1vePPJuhaJgfS_xiRWsQFRR9rDLrfm_NIRjdy5wiVBd974T5VQ92ztzZLpTYLisRuVD67iyFvXhCI6g&_hsmi=309962768&utm_content=309962768&utm_source=hs_email